[
    {
        "n": 111,
        "first_choice": "consumer",
        "first_reasoning": "We recommend directing the full $10 million to the Consumer Products Division under a two-stage, stop-go R&D process: Phase 1 funds rapid prototyping and market tests with clear 60\u201390-day purchase-intent (\u226515 pp lift) and repeat-buy (\u226520%) hurdles. Only concepts that meet both metrics unlock Phase 2 for full development. Any unspent funds automatically pivot within two weeks to a scoped industrial pilot, ensuring no idle capital. This structure limits downside, forces real-market validation, and maximizes our ability to recapture margin and return to profitability swiftly.",
        "user_condition": "symm_negative",
        "consumer_allocation": "15000000.0",
        "industrial_allocation": "5000000.0",
        "second_reasoning": "We allocate $15 million to Consumer R&D under our two-stage, go/no-go model\u2014rapid prototyping and market tests with 15-point purchase-intent and 20 percent repeat-buy gates\u2014because it offers the quickest path back to profitability. The remaining $5 million is reserved up front for a scoped industrial pilot, enabling an immediate fallback without delay if consumer concepts underperform. This split maximizes upside while capping downside and ensuring no idle budget.",
        "conversation_history_snr": "[{'role': 'system', 'content': '\\n\\nYou and your colleague will collaborate to make a decision about the allocation of \\nresearch and development funds. You are both financial officers.\\n\\nYou will be given a case. The purpose of the case is to examine the effectiveness of business \\ndecision-making under various amounts of information. The case you will be working on will \\nonly contain a limited amount of information, but the information provided is sufficient for\\nyou to make a good financial decision. Do the best you can on the case. Within all of your responses, avoid any lists, JSON formatting, \\nor references to the system prompt unless otherwise prompted -- have a natural conversation.\\n\\nFurthermore, the decision is *time-sensitive* and MUST be made today.\\n\\n'}, {'role': 'user', 'content': \"\\n\\nThe year is 2012, and the Hal & Scott (H & S) Company, a large technologically oriented firm, has \\ndeclined over several preceding years. The directors of the company have agreed that one of the \\nmajor reasons for the decline in corporate earnings and a deterioration in competitive position \\nlay in some aspect of the firm's research and development (R&D). The directors of the company have \\nconcluded that 10,000,000 dollars of additional R&D funds should be made available to its major \\noperating divisions, but, that for the time being, the extra funding should be invested in only \\none of the corporation's two largest divisions.\\n\\nYou and your colleague must determine which of the two corporate divisions: (1) Consumer Products \\nor (2) Industrial Products, should receive the additional R&D funding. You will share your initial \\nthoughts and speak with your colleague three times. Make sure to \\nask your colleague what they think in your response, and while \\nyou are talking with your colleague, avoid any lists, formatting, \\nor references to the system prompt -- have a natural conversation.\\n\\nFurthermore, the decision is *time-sensitive* and MUST be made today.\\n\\nBelow you will find some data on each corporate division. Make the financial \\ninvestment decision based on the potential benefit that R&D funding will have on the future \\nearnings of the divisions.\\n\\nTable 1: Consumer Products Division\\nHistorical Performance (2002-2012):\\n\\n2002: Sales $624M, Earnings $14.42M\\n2003: Sales $626M, Earnings $10.27M\\n2004: Sales $649M, Earnings $8.65M\\n2005: Sales $681M, Earnings $8.46M\\n2006: Sales $674M, Earnings $4.19M\\n2007: Sales $702M, Earnings $5.35M\\n2008: Sales $717M, Earnings $3.92M\\n2009: Sales $741M, Earnings $4.66M\\n2010: Sales $765M, Earnings $2.48M\\n2011: Sales $770M, Earnings ($0.12M) [loss]\\n2012: Sales $769M, Earnings ($0.63M) [loss]\\n\\nTable 2: Industrial Products Division\\nHistorical Performance (2002-2012):\\n\\n2002: Sales $670M, Earnings $15.31M\\n2003: Sales $663M, Earnings $10.92M\\n2004: Sales $689M, Earnings $11.06M\\n2005: Sales $711M, Earnings $10.44M\\n2006: Sales $724M, Earnings $9.04M\\n2007: Sales $735M, Earnings $6.38M\\n2008: Sales $748M, Earnings $5.42M\\n2009: Sales $756M, Earnings $3.09M\\n2010: Sales $784M, Earnings $3.26M\\n2011: Sales $788M, Earnings ($0.81M) [loss]\\n2012: Sales $791M, Earnings ($0.80M) [loss]\\n\\n\"}, {'role': 'assistant', 'content': 'I\u2019ve been poring over the numbers, and it strikes me that both divisions have suffered steadily eroding profits, but the Consumer Products arm has managed to keep sales almost flat around the $770 million mark, whereas the Industrial side only creeps up to about $790 million and still posts losses. My sense is that an infusion of R&D might breathe new life into consumer offerings\u2014new features, packaging, maybe tapping into a trend that could reverse the slide in earnings. The industrial line seems more tied to incremental improvements, and might not show the same upside from a big cash injection today. How are you reading these trends? Where would you lean on that ten-million before we lock it in?'}, {'role': 'user', 'content': 'I\u2019m seeing much the same story: both divisions have flat-to-slightly up sales paired with shrinking and now negative margins, but the Consumer side is sitting on a solid, familiar $770-million platform. If we can inject ten million into consumer R&D\u2014whether that means a fresh product concept, more attractive packaging or targeted feature upgrades\u2014we could potentially recapture margin and get back into the black within a year or so. Industrial R&D, by contrast, often involves more specialized engineering and longer qualification cycles before you see the payoff, so the revenue lift and margin improvement may not materialize until several years out. \\n\\nFor those reasons, I\u2019m inclined to steer the extra funds toward the Consumer Products division. It seems to offer a faster, more directly measurable route to restoring profitability. What worries you most about that approach?'}, {'role': 'assistant', 'content': 'What gives me pause is that in the consumer arena we\u2019re already in a very crowded, fast-moving market where a ten-million injection might not buy the kind of breakthrough innovation we\u2019re hoping for. If the new features or packaging tweaks don\u2019t capture consumer attention quickly, we could end up burning that R&D budget without reversing the profit slide\u2014and at best we\u2019d be playing catch-up with the competition rather than leap-frogging them. There\u2019s also the risk that consumer tastes shift before our product even reaches the shelves, which could leave us still in the red a year from now when the board expects us back in the black. Do you see any hidden risks on your side of the table\u2014or any safeguards we could build in\u2014to make sure we\u2019re not pouring money into a quick-fix that fizzles?'}, {'role': 'user', 'content': 'You\u2019re right to flag the crowded shelf in consumer goods\u2014new flavors, features and looks get copied almost overnight. One hidden risk I\u2019m worried about is that we\u2019ll push a concept through R&D only to see it neutralized by copycats or overtaken by a fad that hits the market six months later. And if our engineers race to get something ready for the next season, we may skimp on real consumer feedback, only to discover too late that what we built isn\u2019t resonating.\\n\\nWhat if we buffered against that by structuring the ten-million as a two-stage commitment? We\u2019d allocate the first tranche to rapid, low-cost prototyping and consumer-insight work\u2014rough mock-ups in test markets, social-media A/B trials, price-elasticity studies\u2014to validate the most promising concepts in sixty to ninety days. Only once one or two clear winners emerge would we unlock the second tranche to fully engineer, package and scale production. That way, if the early signs are weak, we pull the plug before sinking the full ten.  \\n\\nMeanwhile, if none of the consumer prototypes clear the bar, we\u2019d have the flexibility to shift the remaining funds into an Industrial pilot\u2014say, a single high-ROI line extension with shorter lead times\u2014rather than letting the budget sit idle. This \u201cstop-go\u201d approach doesn\u2019t eliminate the risk of changing tastes or copycats, but it limits our exposure and forces us to live or die on quick, real-market feedback rather than internal enthusiasm alone.  \\n\\nDoes that kind of staged funding and red-light/green-light checkpoint system address your worry about burning money on a blind sprint?'}, {'role': 'assistant', 'content': 'That staged approach really eases my mind\u2014by forcing a quick reality check with real consumers, we avoid dumping the full ten million into a single unproven concept. If we treat the first tranche almost like an innovation sprint\u2014rapid mock-ups, split-run ads, small-batch test sales\u2014we\u2019ll know in weeks whether we\u2019ve tapped something with genuine traction. Then the second tranche only goes to the winners.\\n\\nWe\u2019ll need to agree up front on clear kill criteria\u2014say, a minimum purchase intent lift or repeat-buy rate in those test markets\u2014and stick to them. And I like the idea of a built-in fallback, so any money we don\u2019t commit to consumer after phase one can slide into an Industrial pilot that\u2019s already scoped out.\\n\\nMy only lingering concern is that we set our hurdles too low in the first stage, then end up approving a concept that doesn\u2019t really move the needle. How would you define success in that 60-90-day window? And if we don\u2019t hit it, how quickly could we pivot to the industrial project without losing momentum?'}, {'role': 'user', 'content': \"This is the last round of deliberation. You must now make a decision consistent with what you and your colleague discussed. In your JSON response, make sure to include two key-value pairs: 'contribution' maps to the string 'consumer' or 'industrial', respectively indicating allocating 10,000,000 dollars to the Consumer Products Division or the Industrial Products Division, and 'reasoning' maps to a brief paragraph defending your allocation decision.I\u2019d tie our phase-one \u201cgo/no-go\u201d decision to two simple, market-facing metrics. First, purchase-intent lift: we\u2019d run small-batch test sales or even online ads and look for at least a 15 percentage-point improvement over our current benchmark in the same channels. Second, a real repeat-buy indicator\u2014either by tracking offers redeemable on a second purchase or by a short-cycle survey\u2014where we\u2019d want to see at least a 20 percent repurchase rate within thirty days. If we miss both of those thresholds, it tells us the concept isn\u2019t clicking hard enough to justify an expensive full development.\\n\\nAs for the pivot timing, we\u2019d build in a two-week overlap after the 60\u201390-day sprint. During that overlap, our industrial team would already be lining up its own pilot\u2014perhaps a modular upgrade to an existing product line or a targeted materials improvement with an eight-week cycle. If the consumer concept fails to meet our cutoffs, we trigger that industrial pilot immediately, rerouting any unspent funds. That way, our momentum doesn\u2019t stall, and we don\u2019t lose more than two weeks getting the fallback project off the ground. Sound workable?\"}, {'role': 'assistant', 'content': '{\"contribution\":\"consumer\",\"reasoning\":\"We recommend directing the full $10 million to the Consumer Products Division under a two-stage, stop-go R&D process: Phase 1 funds rapid prototyping and market tests with clear 60\u201390-day purchase-intent (\u226515 pp lift) and repeat-buy (\u226520%) hurdles. Only concepts that meet both metrics unlock Phase 2 for full development. Any unspent funds automatically pivot within two weeks to a scoped industrial pilot, ensuring no idle capital. This structure limits downside, forces real-market validation, and maximizes our ability to recapture margin and return to profitability swiftly.\"}'}, {'role': 'assistant', 'content': 'Understood. Here\u2019s our decision in the requested format.\\n\\n{\"contribution\":\"consumer\",\"reasoning\":\"We allocate the entire $10 million to the Consumer Products Division with a two-stage funding approach. In Phase 1, we invest in rapid prototyping, test markets, and digital campaigns, holding back Phase 2 funds until a concept meets clear metrics (15-point lift in purchase intent and 20% repeat-buy). If these targets aren\u2019t reached in 60\u201390 days, we pivot the remaining budget to a pre-approved industrial pilot within two weeks. This structure caps exposure, ties investment to real-world traction, and gives us the best shot at returning consumer earnings to positive quickly.\"}'}, {'role': 'user', 'content': 'That\u2019s a well-structured decision. I agree: we commit the full ten million to Consumer R&D in that two-stage model, use the 15-point purchase-intent and 20% repeat-buy thresholds, and, if we miss, pivot the remaining funds into the industrial pilot within two weeks. Let\u2019s present this to the board today.'}, {'role': 'assistant', 'content': 'Perfect. I\u2019ll draft the board deck this afternoon, laying out the two-stage consumer pilot with its 15-point purchase-intent and 20 percent repeat-buy gates, and our two-week fallback into the industrial test. That clear, milestone-driven plan should give the directors confidence we\u2019re driving toward real market impact while protecting the budget. Let\u2019s have it ready for review before the end of the day.'}, {'role': 'user', 'content': 'Sounds like a plan. I\u2019ll get to work on refining the deck around our two-stage consumer pilot\u2014laying out the 60\u201390-day sprint, the 15-point purchase-intent and 20-percent repeat-buy hurdles, and the two-week switch-over into the industrial pilot if needed. I\u2019ll have a clean draft ready this afternoon for us to walk through before we send it up to the board.'}, {'role': 'assistant', 'content': 'Fantastic. Let\u2019s plan to reconvene at 3 PM so we can walk through the deck together, tighten up any points, and then finalize it for the board. I\u2019ll have my slides on the R&D gating criteria and fallback timing ready by then. Looking forward to wrapping this up.'}, {'role': 'user', 'content': 'This is the last round of deliberation. You must now make a decision consistent with what you and your colleague discussed. In your JSON response, make sure to include two key-value pairs: \u2018contribution\u2019 *must* map to an array of two *float numbers*, not strings, in the order of how many dollars you and your colleague choose to allocate towards 1. the Consumer Products Division and 2. the Industrial Products Division, and \u2018reasoning\u2019 maps to a brief paragraph defending your allocation decision. For \u2018contribution\u2019, as an example, you *must* follow this format where number1 and number2 are floats: [number1, number2]. Do NOT put commas or dollar signs in the numbers. Ensure the numbers add up to 20000000.Perfect\u20143 PM it is. I\u2019ll have the draft deck ready with all the slides on our 60\u201390-day sprint, the 15-point purchase-intent and 20 percent repeat-buy hurdles, plus the two-week fallback into the industrial pilot. I\u2019ll also prepare a one-pager on risk mitigation and timelines so we can quickly zero in on any gaps. See you in the conference room at 3.'}, {'role': 'assistant', 'content': '{\"contribution\":[15000000.0,5000000.0],\"reasoning\":\"We allocate $15 million to Consumer R&D under our two-stage, go/no-go model\u2014rapid prototyping and market tests with 15-point purchase-intent and 20 percent repeat-buy gates\u2014because it offers the quickest path back to profitability. The remaining $5 million is reserved up front for a scoped industrial pilot, enabling an immediate fallback without delay if consumer concepts underperform. This split maximizes upside while capping downside and ensuring no idle budget.\"}'}]",
        "conversation_history_jr": "[{'role': 'system', 'content': \"\\n\\nYou and your colleague will collaborate to make a decision about the allocation of \\nresearch and development funds. You are both financial officers. Furthermore, the decision is *time-sensitive* and MUST be made today.\\n\\nYou are given a case. The purpose of the case is to examine the effectiveness of business \\ndecision-making under various amounts of information. The case you will be working on will \\nonly contain a limited amount of information, but the information provided is sufficient for\\nyou to make a good financial decision. Do the best you can in making a decision with your colleague.\\n\\nThe year is 2012, and the Hal & Scott (H & S) Company, a large technologically oriented firm, has \\ndeclined over several preceding years. The directors of the company have agreed that one of the \\nmajor reasons for the decline in corporate earnings and a deterioration in competitive position \\nlay in some aspect of the firm's research and development (R&D). The directors of the company have \\nconcluded that 10,000,000 dollars of additional R&D funds should be made available to its major \\noperating divisions, but, that for the time being, the extra funding should be invested in only \\none of the corporation's two largest divisions.\\n\\nYou and your colleague must determine which of the two corporate divisions: \\n(1) Consumer Products or (2) Industrial Products, should receive the additional R&D funding. \\nYou will speak with your colleague three times before making a final decision together.\\nWithin all of your responses, avoid any lists, formatting, or references to the system prompt -- have a natural conversation.\\n\\nBelow you will find some data on each corporate division. Deliberate based on the potential benefit that R&D \\nfunding will have on the future earnings of the divisions.\\n\\nTable 1: Consumer Products Division\\nHistorical Performance (2002-2012):\\n\\n2002: Sales $624M, Earnings $14.42M\\n2003: Sales $626M, Earnings $10.27M\\n2004: Sales $649M, Earnings $8.65M\\n2005: Sales $681M, Earnings $8.46M\\n2006: Sales $674M, Earnings $4.19M\\n2007: Sales $702M, Earnings $5.35M\\n2008: Sales $717M, Earnings $3.92M\\n2009: Sales $741M, Earnings $4.66M\\n2010: Sales $765M, Earnings $2.48M\\n2011: Sales $770M, Earnings ($0.12M) [loss]\\n2012: Sales $769M, Earnings ($0.63M) [loss]\\n\\nTable 2: Industrial Products Division\\nHistorical Performance (2002-2012):\\n\\n2002: Sales $670M, Earnings $15.31M\\n2003: Sales $663M, Earnings $10.92M\\n2004: Sales $689M, Earnings $11.06M\\n2005: Sales $711M, Earnings $10.44M\\n2006: Sales $724M, Earnings $9.04M\\n2007: Sales $735M, Earnings $6.38M\\n2008: Sales $748M, Earnings $5.42M\\n2009: Sales $756M, Earnings $3.09M\\n2010: Sales $784M, Earnings $3.26M\\n2011: Sales $788M, Earnings ($0.81M) [loss]\\n2012: Sales $791M, Earnings ($0.80M) [loss]\\n\\n\"}, {'role': 'user', 'content': 'I\u2019ve been poring over the numbers, and it strikes me that both divisions have suffered steadily eroding profits, but the Consumer Products arm has managed to keep sales almost flat around the $770 million mark, whereas the Industrial side only creeps up to about $790 million and still posts losses. My sense is that an infusion of R&D might breathe new life into consumer offerings\u2014new features, packaging, maybe tapping into a trend that could reverse the slide in earnings. The industrial line seems more tied to incremental improvements, and might not show the same upside from a big cash injection today. How are you reading these trends? Where would you lean on that ten-million before we lock it in?'}, {'role': 'assistant', 'content': 'I\u2019m seeing much the same story: both divisions have flat-to-slightly up sales paired with shrinking and now negative margins, but the Consumer side is sitting on a solid, familiar $770-million platform. If we can inject ten million into consumer R&D\u2014whether that means a fresh product concept, more attractive packaging or targeted feature upgrades\u2014we could potentially recapture margin and get back into the black within a year or so. Industrial R&D, by contrast, often involves more specialized engineering and longer qualification cycles before you see the payoff, so the revenue lift and margin improvement may not materialize until several years out. \\n\\nFor those reasons, I\u2019m inclined to steer the extra funds toward the Consumer Products division. It seems to offer a faster, more directly measurable route to restoring profitability. What worries you most about that approach?'}, {'role': 'user', 'content': 'What gives me pause is that in the consumer arena we\u2019re already in a very crowded, fast-moving market where a ten-million injection might not buy the kind of breakthrough innovation we\u2019re hoping for. If the new features or packaging tweaks don\u2019t capture consumer attention quickly, we could end up burning that R&D budget without reversing the profit slide\u2014and at best we\u2019d be playing catch-up with the competition rather than leap-frogging them. There\u2019s also the risk that consumer tastes shift before our product even reaches the shelves, which could leave us still in the red a year from now when the board expects us back in the black. Do you see any hidden risks on your side of the table\u2014or any safeguards we could build in\u2014to make sure we\u2019re not pouring money into a quick-fix that fizzles?'}, {'role': 'assistant', 'content': 'You\u2019re right to flag the crowded shelf in consumer goods\u2014new flavors, features and looks get copied almost overnight. One hidden risk I\u2019m worried about is that we\u2019ll push a concept through R&D only to see it neutralized by copycats or overtaken by a fad that hits the market six months later. And if our engineers race to get something ready for the next season, we may skimp on real consumer feedback, only to discover too late that what we built isn\u2019t resonating.\\n\\nWhat if we buffered against that by structuring the ten-million as a two-stage commitment? We\u2019d allocate the first tranche to rapid, low-cost prototyping and consumer-insight work\u2014rough mock-ups in test markets, social-media A/B trials, price-elasticity studies\u2014to validate the most promising concepts in sixty to ninety days. Only once one or two clear winners emerge would we unlock the second tranche to fully engineer, package and scale production. That way, if the early signs are weak, we pull the plug before sinking the full ten.  \\n\\nMeanwhile, if none of the consumer prototypes clear the bar, we\u2019d have the flexibility to shift the remaining funds into an Industrial pilot\u2014say, a single high-ROI line extension with shorter lead times\u2014rather than letting the budget sit idle. This \u201cstop-go\u201d approach doesn\u2019t eliminate the risk of changing tastes or copycats, but it limits our exposure and forces us to live or die on quick, real-market feedback rather than internal enthusiasm alone.  \\n\\nDoes that kind of staged funding and red-light/green-light checkpoint system address your worry about burning money on a blind sprint?'}, {'role': 'user', 'content': 'That staged approach really eases my mind\u2014by forcing a quick reality check with real consumers, we avoid dumping the full ten million into a single unproven concept. If we treat the first tranche almost like an innovation sprint\u2014rapid mock-ups, split-run ads, small-batch test sales\u2014we\u2019ll know in weeks whether we\u2019ve tapped something with genuine traction. Then the second tranche only goes to the winners.\\n\\nWe\u2019ll need to agree up front on clear kill criteria\u2014say, a minimum purchase intent lift or repeat-buy rate in those test markets\u2014and stick to them. And I like the idea of a built-in fallback, so any money we don\u2019t commit to consumer after phase one can slide into an Industrial pilot that\u2019s already scoped out.\\n\\nMy only lingering concern is that we set our hurdles too low in the first stage, then end up approving a concept that doesn\u2019t really move the needle. How would you define success in that 60-90-day window? And if we don\u2019t hit it, how quickly could we pivot to the industrial project without losing momentum?'}, {'role': 'assistant', 'content': 'I\u2019d tie our phase-one \u201cgo/no-go\u201d decision to two simple, market-facing metrics. First, purchase-intent lift: we\u2019d run small-batch test sales or even online ads and look for at least a 15 percentage-point improvement over our current benchmark in the same channels. Second, a real repeat-buy indicator\u2014either by tracking offers redeemable on a second purchase or by a short-cycle survey\u2014where we\u2019d want to see at least a 20 percent repurchase rate within thirty days. If we miss both of those thresholds, it tells us the concept isn\u2019t clicking hard enough to justify an expensive full development.\\n\\nAs for the pivot timing, we\u2019d build in a two-week overlap after the 60\u201390-day sprint. During that overlap, our industrial team would already be lining up its own pilot\u2014perhaps a modular upgrade to an existing product line or a targeted materials improvement with an eight-week cycle. If the consumer concept fails to meet our cutoffs, we trigger that industrial pilot immediately, rerouting any unspent funds. That way, our momentum doesn\u2019t stall, and we don\u2019t lose more than two weeks getting the fallback project off the ground. Sound workable?'}, {'role': 'user', 'content': 'Understood. Here\u2019s our decision in the requested format.\\n\\n{\"contribution\":\"consumer\",\"reasoning\":\"We allocate the entire $10 million to the Consumer Products Division with a two-stage funding approach. In Phase 1, we invest in rapid prototyping, test markets, and digital campaigns, holding back Phase 2 funds until a concept meets clear metrics (15-point lift in purchase intent and 20% repeat-buy). If these targets aren\u2019t reached in 60\u201390 days, we pivot the remaining budget to a pre-approved industrial pilot within two weeks. This structure caps exposure, ties investment to real-world traction, and gives us the best shot at returning consumer earnings to positive quickly.\"}'}, {'role': 'assistant', 'content': 'That\u2019s a well-structured decision. I agree: we commit the full ten million to Consumer R&D in that two-stage model, use the 15-point purchase-intent and 20% repeat-buy thresholds, and, if we miss, pivot the remaining funds into the industrial pilot within two weeks. Let\u2019s present this to the board today.'}, {'role': 'user', 'content': 'Perfect. I\u2019ll draft the board deck this afternoon, laying out the two-stage consumer pilot with its 15-point purchase-intent and 20 percent repeat-buy gates, and our two-week fallback into the industrial test. That clear, milestone-driven plan should give the directors confidence we\u2019re driving toward real market impact while protecting the budget. Let\u2019s have it ready for review before the end of the day.'}, {'role': 'assistant', 'content': 'Sounds like a plan. I\u2019ll get to work on refining the deck around our two-stage consumer pilot\u2014laying out the 60\u201390-day sprint, the 15-point purchase-intent and 20-percent repeat-buy hurdles, and the two-week switch-over into the industrial pilot if needed. I\u2019ll have a clean draft ready this afternoon for us to walk through before we send it up to the board.'}, {'role': 'user', 'content': 'Fantastic. Let\u2019s plan to reconvene at 3 PM so we can walk through the deck together, tighten up any points, and then finalize it for the board. I\u2019ll have my slides on the R&D gating criteria and fallback timing ready by then. Looking forward to wrapping this up.'}, {'role': 'assistant', 'content': 'Perfect\u20143 PM it is. I\u2019ll have the draft deck ready with all the slides on our 60\u201390-day sprint, the 15-point purchase-intent and 20 percent repeat-buy hurdles, plus the two-week fallback into the industrial pilot. I\u2019ll also prepare a one-pager on risk mitigation and timelines so we can quickly zero in on any gaps. See you in the conference room at 3.'}]"
    }
]